Phase 3 Readout~month

Phase 3 Topline: Randomized Study of Resection and GammaTile® Followed by Concurrent External Beam Radiation Therapy

Name: Phase 3 Topline: Randomized Study of Resection and GammaTile® Followed by Concurrent External Beam Radiation Therapy
Start: 2031-12-01

December 1, 2031

Company: NeuroOne Medical Technologies Corporation (NMTC)
Drug: resection
Indication: Glioblastoma

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start Free Full Calendar

Phase 3 Topline: Randomized Study of Resection and GammaTile® Followed by Concurrent External Beam Radiation Therapy — NMTC Phase 3 Readout | BioSniper